| Laurie A Chu, MD | |
|
9400 Rosecrans Ave, Bellflower, CA 90706-2246 | |
| (562) 461-3000 | |
| Not Available |
| Full Name | Laurie A Chu |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 31 Years |
| Location | 9400 Rosecrans Ave, Bellflower, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013084029 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | G80139 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Downey | Downey, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
A long-term initiative championed by the UK Research and Innovation Council could significantly improve the health and life prospects of a generation of Africa's youth.
Osteoarthritis of the hip and knee is among the most common joint disorders. A frequently performed treatment for osteoarthritis and other joint related pain syndromes are IACS, yet there is conflicting evidence on their potential benefit and possible negative outcomes following such injections.
A new study led by scientists at The Scripps Research Institute is giving researchers a first look at the early stages of brain development in patients with Fragile X syndrome, a disorder that causes mild to severe intellectual disability and is the most common genetic cause of autism spectrum disorder.
A startup based on University of Helsinki research offers solutions for the interaction problems that arise from memory disorders.
Northwest Biotherapeutics, a biotechnology company developing DCVax-L personalized immune therapies for solid tumor cancers, today announced that its Phase III clinical trial with DCVax-L for brain cancer has been initiated at King's College Hospital in the UK.
› Verified 5 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
A long-term initiative championed by the UK Research and Innovation Council could significantly improve the health and life prospects of a generation of Africa's youth.
Osteoarthritis of the hip and knee is among the most common joint disorders. A frequently performed treatment for osteoarthritis and other joint related pain syndromes are IACS, yet there is conflicting evidence on their potential benefit and possible negative outcomes following such injections.
A new study led by scientists at The Scripps Research Institute is giving researchers a first look at the early stages of brain development in patients with Fragile X syndrome, a disorder that causes mild to severe intellectual disability and is the most common genetic cause of autism spectrum disorder.
A startup based on University of Helsinki research offers solutions for the interaction problems that arise from memory disorders.
Northwest Biotherapeutics, a biotechnology company developing DCVax-L personalized immune therapies for solid tumor cancers, today announced that its Phase III clinical trial with DCVax-L for brain cancer has been initiated at King's College Hospital in the UK.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laurie A Chu, MD 9400 Rosecrans Ave, Bellflower, CA 90706-2246 Ph: (562) 461-3000 | Laurie A Chu, MD 9400 Rosecrans Ave, Bellflower, CA 90706-2246 Ph: (562) 461-3000 |
News Archive
A long-term initiative championed by the UK Research and Innovation Council could significantly improve the health and life prospects of a generation of Africa's youth.
Osteoarthritis of the hip and knee is among the most common joint disorders. A frequently performed treatment for osteoarthritis and other joint related pain syndromes are IACS, yet there is conflicting evidence on their potential benefit and possible negative outcomes following such injections.
A new study led by scientists at The Scripps Research Institute is giving researchers a first look at the early stages of brain development in patients with Fragile X syndrome, a disorder that causes mild to severe intellectual disability and is the most common genetic cause of autism spectrum disorder.
A startup based on University of Helsinki research offers solutions for the interaction problems that arise from memory disorders.
Northwest Biotherapeutics, a biotechnology company developing DCVax-L personalized immune therapies for solid tumor cancers, today announced that its Phase III clinical trial with DCVax-L for brain cancer has been initiated at King's College Hospital in the UK.
› Verified 5 days ago
Basil Z. Abdelkarim, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Darren K. Shimabukuro, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Jennifer T. Nguyen, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Dr. Ana Franco Borgas, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Module 3200, Bellflower, CA 90706 Phone: 562-461-4033 Fax: 562-461-4047 | |
Edward H. Wang, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 | |
Earl Bautista, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9400 Rosecrans Ave, Bellflower, CA 90706 Phone: 562-461-3000 |